Panagiota Maravelia

Research

My main research phd objectives are to develop novel immunotherapies in the
form of vaccines and TCR T cell based therapies for the treatment of chronic
viral hepatitis B &
D infection and liver cancer, respectively.

Article: JOURNAL OF INFECTIOUS DISEASES. 2021;223(1):128-138

Blocking Entry of Hepatitis B and D Viruses to Hepatocytes as a Novel Immunotherapy for Treating Chronic Infections.

Maravelia P; Frelin L; Ni Y; Caro Pérez N; Ahlén G; Jagya N; Verch G; Verhoye L; Pater L; Johansson M; Pasetto A; Meuleman P; Urban S; Sällberg M
Article: IMMUNITY INFLAMMATION AND DISEASE. 2020;8(1):8-23

PD-1 expression affects cytokine production by ILC2 and is influenced by peroxisome proliferator-activated receptor-γ.

Batyrova B; Luwaert F; Maravelia P; Miyabayashi Y; Vashist N; Stark JM; Soori SY; Tibbitt CA; Riese P; Coquet JM; Chambers BJ

Research Assistant, Department of Laboratory Medicine, Karolinska Institutet, 2016-
Phd Student, Department of Laboratory Medicine, Karolinska Institutet, 2019-2023

Degree Of Doctor Of Philosophy, Department of Laboratory Medicine, Karolinska Institutet, 2024